Fig. 4From: Increased sialylation of site specific O-glycoforms of hemopexin in liver diseaseROC curve analysis of progressing liver disease. ROC curves comparing the following groups based on measurement of S-HPX: a discovery: control (n = 23) versus fibrosis (n = 22) and fibrosis (n = 22) versus cirrhosis (n = 24); b validation: control (n = 15) versus fibrosis (n = 15) and fibrosis (n = 15) versus cirrhosis (n = 15)Back to article page